Midkine is a potent regulator of the catecholamine biosynthesis pathway in mouse aorta

Life Sciences

Volumn 79, Issue 11, 2006, Pages 1049-1055

  Ezquerra, Laura ^a,b   Herradon, Gonzalo ^a,b   Nguyen, Trang ^b   Silos Santiago, Inmaculada ^b   Deuel, Thomas F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

Aorta; Catecholamines; Midkine; Pleiotrophin; Tyrosine hydroxylase

Indexed keywords

ADRENALIN; AROMATIC LEVO AMINO ACID DECARBOXYLASE; CATECHOLAMINE; DOPAMINE BETA MONOOXYGENASE; MIDKINE; NORADRENALIN; PHENYLETHANOLAMINE N METHYLTRANSFERASE; PLEIOTROPHIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; AORTA; ARTICLE; CATALYSIS; CATECHOLAMINE SYNTHESIS; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME REGULATION; GENETIC TRANSCRIPTION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; AORTA; CARRIER PROTEINS; CATECHOLAMINES; CYTOKINES; DOPA DECARBOXYLASE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MICE; MICE, KNOCKOUT; MIXED FUNCTION OXYGENASES; NOREPINEPHRINE; RNA, MESSENGER;

EID: 33746000374     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.03.013     Document Type: Article

References (61)

1. Barth W., Deten A., Bauer M., Reinohs M., Leicht M., and Zimmer H.G. Differential remodeling of the left and right heart after norepinephrine treatment in rats: studies on cytokines and collagen. Journal of Molecular and Cellular Cardiology 32 (2000) 273-284
2. Beecken W.D., Kramer W., and Jonas D. New molecular mediators in tumor angiogenesis. Journal of Cellular and Molecular Medicine 4 (2000) 262-269
3. Bhambi B., and Eghbali M. Effect of norepinephrine on myocardial collagen gene expression and response of cardiac fibroblasts after norepinephrine treatment. American Journal of Pathology 139 (1991) 1131-1142
4. Chauhan A.K., Li Y.S., and Deuel T.F. Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice. Proceedings of the National Academy of Sciences of the United States of America 90 (1993) 679-682
5. Christman K.L., Fang Q., Kim A.J., Sievers R.E., Fok H.H., Candia A.F., Colley K.J., Herradon G., Ezquerra L., Deuel T.F., and Lee R.J. Pleiotrophin induces formation of functional neovasculature in vivo. Biochemical and Biophysical Research Communications 332 (2005) 1146-1152
6. Czubayko F., Schulte A.M., Berchem G.J., and Wellstein A. Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin. Proceedings of the National Academy of Sciences of the United States of America 93 (1996) 14753-14758
7. Deuel T.F., Zhang N., Yeh H.J., Silos-Santiago I., and Wang Z.Y. Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway. Archives of Biochemistry and Biophysics 397 (2002) 162-171
8. Dogan M.D., Sumners C., Broxson C.S., Clark N., and Tumer N. Central angiotensin II increases biosynthesis of tyrosine hydroxylase in the rat adrenal medulla. Biochemical and Biophysical Research Communications 313 (2004) 623-626
9. Eide I., Kolloch R., De Quattro V., Miano L., Dugger R., and Van der Meulen J. Raised cerebrospinal fluid norepinephrine in some patients with primary hypertension. Hypertension 1 (1979) 255-260
10. Escobar E., Rodriguez-Reyna T.S., Arrieta O., and Sotelo J. Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer. Current Vascular Pharmacology 2 (2004) 385-399
11. Ezquerra L., Herradon G., Nguyen T., Vogt T.F., Bronson R., Silos-Santiago I., and Deuel T.F. Pleiotrophin is a major regulator of the catecholamine biosynthesis pathway in mouse aorta. Biochemical and Biophysical Research Communications 323 (2004) 512-517
12. Ezquerra L., Herradon G., Nguyen T., Silos-Santiago I., and Deuel T.F. Midkine, a newly discovered regulator of the renin-angiotensin pathway in mouse aorta: significance of the pleiotrophin/midkine developmental gene family in angiotensin II signaling. Biochemical and Biophysical Research Communications 333 (2005) 636-643
13. Fang W., Hartmann N., Chow D.T., Riegel A.T., and Wellstein A. Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer. Journal of Biological Chemistry 267 (1992) 25889-25897
14. Guimaraes S., and Moura D. Vascular adrenoceptors: an update. Pharmacological Reviews 53 (2001) 319-356
15. Hayashi K., Banno H., Kadomatsu K., Takei Y., Komori K., and Muramatsu T. Antisense oligodeoxyribonucleotide as to the growth factor midkine suppresses neointima formation induced by balloon injury. American Journal of Physiology. Heart and Circulatory Physiology (2005)
16. Herradon G., Ezquerra L., Nguyen T., Vogt T.F., Bronson R., Silos-Santiago I., and Deuel T.F. Pleiotrophin is an important regulator of the renin-angiotensin system in mouse aorta. Biochemical and Biophysical Research Communications 324 (2004) 1041-1047
17. Herradon G., Ezquerra L., Nguyen T., Silos-Santiago I., and Deuel T.F. Midkine regulates pleiotrophin organ-specific gene expression: evidence for transcriptional regulation and functional redundancy within the pleiotrophin/midkine developmental gene family. Biochemical and Biophysical Research Communications 333 (2005) 714-721
18. Horiba M., Kadomatsu K., Nakamura E., Muramatsu H., Ikematsu S., Sakuma S., Hayashi K., Yuzawa Y., Matsuo S., Kuzuya M., Kaname T., Hirai M., Saito H., and Muramatsu T. Neointima formation in a restenosis model is suppressed in midkine-deficient mice. Journal of Clinical Investigation 105 (2000) 489-495
19. Iwashita N., Muramatsu H., Toriyama K., Torii S., and Muramatsu T. Expression of midkine in normal and burn sites of rat skin. Burns 25 (1999) 119-124
20. Jezova M., Armando I., Bregonzio C., Yu Z.X., Qian S., Ferrans V.J., Imboden H., and Saavedra J.M. Angiotensin II AT(1) and AT(2) receptors contribute to maintain basal adrenomedullary norepinephrine synthesis and tyrosine hydroxylase transcription. Endocrinology 144 (2003) 2092-2101
21. Kadomatsu K., Tomomura M., and Muramatsu T. cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochemical and Biophysical Research Communications 151 (1988) 1312-1318
22. Kadomatsu K., Hagihara M., Akhter S., Fan Q.W., Muramatsu H., and Muramatsu T. Midkine induces the transformation of NIH3T3 cells. British Journal of Cancer 75 (1997) 354-359
23. Kaneda N., Talukder A.H., Nishiyama H., Koizumi S., and Muramatsu T. Midkine, a heparin-binding growth/differentiation factor, exhibits nerve cell adhesion and guidance activity for neurite outgrowth in vitro. Journal of Biochemistry (Tokyo) 119 (1996) 1150-1156
24. Kawai H., Stevens S.Y., and Liang C.S. Renin-angiotensin system inhibition on noradrenergic nerve terminal function in pacing-induced heart failure. American Journal of Physiology. Heart and Circulatory Physiology 279 (2000) H3012-H3019
25. Koshizawa S.H., Matsumura T., Kadono Y., Sawada T., Kadomatsu K., Muramatsu H., and Muramatsu T. Alteration of midkine expression associated with chemically-induced differentiation in human neuroblastoma cells. Cancer Letter 111 (1997) 117-125
26. Kumai T., Tateishi T., Tanaka M., Watanabe M., Shimizu H., and Kobayashi S. Tyrosine hydroxylase antisense gene therapy causes hypotensive effects in the spontaneously hypertensive rats. Journal Hypertension 19 (2001) 1769-1773
27. Li Y.S., Milner P.G., Chauhan A.K., Watson M.A., Hoffman R.M., Kodner C.M., Milbrandt J., and Deuel T.F. Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science 250 (1990) 1690-1694
28. Li Y.S., Gurrieri M., and Deuel T.F. Pleiotrophin gene expression is highly restricted and is regulated by platelet-derived growth factor. Biochemical and Biophysical Research Communications 184 (1992) 427-432
29. Lindberg H., Nielsen D., Jensen B.V., Eriksen J., and Skovsgaard T. Angiotensin converting enzyme inhibitors for cancer treatment?. Acta Oncologica 43 (2004) 142-152
30. Ma F.Y., Grattan D.R., Bobrovskaya L., Dunkley P.R., and Bunn S.J. Angiotensin II regulates tyrosine hydroxylase activity and mRNA expression in rat mediobasal hypothalamic cultures: the role of specific protein kinases. Journal of Neurochemistry 90 (2004) 431-441
31. Maekawa T., Waki S., Okada A., Fukui H., Kinoshita Y., and Chiba T. Midkine gene expression in the healing process of gastric ulcer. Journal of Laboratory and Clinical Medicine 133 (1999) 349-352
32. Mashour G.A., Ratner N., Khan G.A., Wang H.L., Martuza R.L., and Kurtz A. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells. Oncogene 20 (2001) 97-105
33. Mentlein R., and Held-Feindt J. Pleiotrophin, an angiogenic and mitogenic growth factor, is expressed in human gliomas. Journal of Neurochemistry 83 (2002) 747-753
34. Michikawa M., Kikuchi S., Muramatsu H., Muramatsu T., and Kim S.U. Retinoic acid responsive gene product, midkine, has neurotrophic functions for mouse spinal cord and dorsal root ganglion neurons in culture. Journal of Neuroscience Research 35 (1993) 530-539
35. Milner P.G., Li Y.S., Hoffman R.M., Kodner C.M., Siegel N.R., and Deuel T.F. A novel 17 kD heparin-binding growth factor (HBGF-8) in bovine uterus: purification and N-terminal amino acid sequence. Biochemical and biophysical research communications 165 (1989) 1096-1103
36. Mitsiadis T.A., Salmivirta M., Muramatsu T., Muramatsu H., Rauvala H., Lehtonen E., Jalkanen M., and Thesleff I. Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis. Development 121 (1995) 37-51
37. Moser M., and Setaro J. Continued importance of diuretics and beta-adrenergic blockers in the management of hypertension. Medical Clinics of North America 88 (2004) 167-187
38. Muramatsu T. Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. Journal of Biochemistry (Tokyo) 132 (2002) 359-371
39. Muramatsu H., Shirahama H., Yonezawa S., Maruta H., and Muramatsu T. Midkine, a retinoic acid-inducible growth/differentiation factor: immunochemical evidence for the function and distribution. Developments in Biologicals 159 (1993) 392-402
40. Nakagawara A., Milbrandt J., Muramatsu T., Deuel T.F., Zhao H., Cnaan A., and Brodeur G.M. Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Research 55 (1995) 1792-1797
41. Nakamoto M., Matsubara S., Miyauchi T., Obama H., Ozawa M., and Muramatsu T. A new family of heparin binding growth/differentiation factors: differential expression of the midkine (MK) and HB-GAM genes during mouse development. Journal of Biochemistry (Tokyo) 112 (1992) 346-349
42. Nakamura E., Kadomatsu K., Yuasa S., Muramatsu H., Mamiya T., Nabeshima T., Fan Q.W., Ishiguro K., Igakura T., Matsubara S., Kaname T., Horiba M., Saito H., and Muramatsu T. Disruption of the midkine gene (Mdk) resulted in altered expression of a calcium binding protein in the hippocampus of infant mice and their abnormal behaviour. Genes Cells 3 (1998) 811-822
43. Nakanishi T., Kadomatsu K., Okamoto T., Tomoda Y., and Muramatsu T. Expression of midkine and pleiotropin in ovarian tumors. Obstetrics and gynecology 90 (1997) 285-290
44. Orlowska-Baranowska E., Placha G., Gaciong Z., Baranowski R., Zakrzewski D., Michalek P., Hoffman P., and Rawczynska-Englert I. Influence of ACE I/D genotypes on left ventricular hypertrophy in aortic stenosis: gender-related differences. Journal of Heart Valve Disease 13 (2004) 574-581
45. Petersen W., Wildemann B., Pufe T., Raschke M., and Schmidmaier G. The angiogenic peptide pleiotrophin (PTN/HB-GAM) is expressed in fracture healing: an immunohistochemical study in rats. Archives of Orthopaedic and Trauma Surgery 124 (2004) 603-607
46. Prichard B.N., Cruickshank J.M., and Graham B.R. Beta-adrenergic blocking drugs in the treatment of hypertension. Blood Press 10 (2001) 366-386
47. Pufe T., Bartscher M., Petersen W., Tillmann B., and Mentlein R. Expression of pleiotrophin, an embryonic growth and differentiation factor, in rheumatoid arthritis. Arthritis and Rheumatism 48 (2003) 660-667
48. Shimizu H., Kumai T., and Kobayashi S. Involvement of tyrosine hydroxylase upregulation in cyclosporine-induced hypertension. Japanese Journal of Pharmacology 85 (2001) 306-312
49. Silos-Santiago I., Yeh H.J., Gurrieri M.A., Guillerman R.P., Li Y.S., Wolf J., Snider W., and Deuel T.F. Localization of pleiotrophin and its mRNA in subpopulations of neurons and their corresponding axonal tracts suggests important roles in neural-glial interactions during development and in maturity. Journal of Neurobiology 31 (1996) 283-296
50. Stoica G.E., Kuo A., Powers C., Bowden E.T., Sale E.B., Riegel A.T., and Wellstein A. Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types. Journal of Biological Chemistry 277 (2002) 35990-35998
51. Takei Y., Kadomatsu K., Yuasa K., Sato W., and Muramatsu T. Morpholino antisense oligomer targeting human midkine: its application for cancer therapy. International Journal of Cancer 114 (2005) 490-497
52. Takekoshi K., Ishii K., Shibuya S., Kawakami Y., Isobe K., and Nakai T. Angiotensin II type 2 receptor counter-regulates type 1 receptor in catecholamine synthesis in cultured porcine adrenal medullary chromaffin cells. Hypertension 39 (2002) 142-148
53. Tiong A.Y., and Brieger D. Inflammation and coronary artery disease. American Heart Journal 150 (2005) 11-18 (Review)
54. Tsuru H., Tanimitsu N., and Hirai T. Role of perivascular sympathetic nerves and regional differences in the features of sympathetic innervation of the vascular system. Japanese Journal of Pharmacology 88 (2002) 9-13
55. Usui T., Yamagami S., Yokoo S., Mimura T., Ono K., and Amano S. Gene expression profile in corneal neovascularization identified by immunology related macroarray. Molecular Vision 10 (2004) 832-836
56. Vanderwinden J.M., Mailleux P., Schiffmann S.N., and Vanderhaeghen J.J. Cellular distribution of the new growth factor pleiotrophin (HB-GAM) mRNA in developing and adult rat tissues. Anatomy and Embryology (Berl.) 186 (1992) 387-406
57. Whitfield M.L., Finlay D.R., Murray J.I., Troyanskaya O.G., Chi J.T., Pergamenschikov A., McCalmont T.H., Brown P.O., Botstein D., and Connolly M.K. Systemic and cell type-specific gene expression patterns in scleroderma skin. Proceedings of the National Academy of Sciences of the United States of America 100 (2003) 12319-12324
58. Yeh H.J., He Y.Y., Xu J., Hsu C.Y., and Deuel T.F. Upregulation of pleiotrophin gene expression in developing microvasculature, macrophages, and astrocytes after acute ischemic brain injury. Journal of Neuroscience 18 (1998) 3699-3707
59. Yoshiji H., Kuriyama S., and Fukui H. Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor. Tumour Biology 23 (2002) 348-356
60. Zhang N., and Deuel T.F. Pleiotrophin and midkine, a family of mitogenic and angiogenic heparin-binding growth and differentiation factors. Current Opinion in Hematology 6 (1999) 44-50
61. Zhang N., Zhong R., Wang Z.Y., and Deuel T.F. Human breast cancer growth inhibited in vivo by a dominant negative pleiotrophin mutant. Journal of Biological Chemistry 272 (1997) 16733-16736